Anemic syndrome: detailed review
(iron deficiency, vitamin B12/folate deficiency, hypo-aplastic, hemolytic anemia)
Anemia is a clinical-hematologic syndrome defined by reduced hemoglobin (and usually RBC mass), causing impaired oxygen delivery.
Typical symptoms across all types: fatigue, weakness, pallor, exertional dyspnea, tachycardia, dizziness.
1) Iron-deficiency anemia (IDA)
Pathophysiology
Iron is required for heme synthesis. Deficiency causes reduced hemoglobin production, producing microcytic hypochromic RBCs.
Causes
- Chronic blood loss (most common in adults)
- GI: ulcer, gastritis, colorectal cancer, angiodysplasia, NSAID-related bleeding
- Gynecologic: menorrhagia, uterine pathology
- Increased demand: pregnancy, growth
- Low intake: poor diet
- Malabsorption: celiac disease, post-gastrectomy, achlorhydria, H. pylori-associated states
Clinical features
- General anemia symptoms
- Pica (ice/clay craving), brittle hair/nails, koilonychia
- Angular cheilitis, glossitis, restless legs (sometimes)
Lab profile
- CBC: Hb low, MCV low, MCH low, often RDW high
- Iron studies:
- Ferritin low (most specific for depleted stores)
- Serum iron low
- TIBC/transferrin high
- Transferrin saturation low
- Reticulocytes: low/normal before treatment
- Smear: microcytosis, hypochromia, anisopoikilocytosis
Diagnostic strategy
- Confirm iron deficiency biochemically
- Then identify etiology of iron loss, especially occult GI bleeding in adults
Treatment
- Treat cause (bleeding source, malabsorption)
- Iron replacement
- Oral ferrous salts first line
- IV iron if intolerance, severe deficiency, malabsorption, CKD/inflammation
- Follow response:
- Reticulocyte rise in about 1 week
- Hb rise over 2-4 weeks
- Continue therapy after Hb normalization to replenish stores
Complications if untreated
- Reduced physical/cognitive performance
- Pregnancy risks (preterm birth, low birth weight)
- Cardiac strain in severe chronic anemia
2) Vitamin B12 and folate deficiency anemia (megaloblastic anemia)
Pathophysiology
Both B12 and folate are required for DNA synthesis. Deficiency causes nuclear maturation delay and ineffective erythropoiesis, leading to macrocytosis/megaloblastosis.
2A) Vitamin B12 deficiency
Causes
- Pernicious anemia (intrinsic factor deficiency)
- Gastric surgery/atrophic gastritis
- Terminal ileal disease or resection (e.g., Crohn disease)
- Long-term strict vegan diet (without supplementation)
- Bacterial overgrowth, pancreatic insufficiency, some medications
Clinical features
- Anemia symptoms + glossitis
- Neurologic signs: paresthesia, loss of vibration/proprioception, ataxia, cognitive/psychiatric changes
- Neurologic damage can become irreversible if delayed treatment
Labs
- CBC: macrocytic anemia (MCV high)
- Smear: macro-ovalocytes, hypersegmented neutrophils
- B12 low
- Methylmalonic acid high
- Homocysteine high
- Reticulocytes low before treatment
Treatment
- B12 replacement (parenteral in severe/neurologic or malabsorption states; high-dose oral in selected cases)
- Treat underlying cause
- Monitor reticulocyte response and neurologic recovery
2B) Folate deficiency
Causes
- Poor intake (malnutrition, alcoholism)
- Increased need (pregnancy, hemolysis)
- Malabsorption
- Drugs (methotrexate, trimethoprim, phenytoin)
Clinical features
- Anemia symptoms, glossitis
- No typical neurologic syndrome like B12 deficiency
Labs
- Macrocytic anemia, hypersegmented neutrophils
- Folate low
- Homocysteine high
- Methylmalonic acid normal
Treatment
- Folic acid replacement
- Correct precipitating cause
- Always exclude/cover B12 deficiency before folate-only therapy
3) Hypo-aplastic (aplastic) anemia
Definition
Bone marrow failure characterized by hypocellular marrow and peripheral pancytopenia.
Pathogenesis
Most often immune-mediated stem cell destruction; can be idiopathic or secondary.
Causes
- Idiopathic (common)
- Drugs/toxins (e.g., benzene, some chemotherapeutics, chloramphenicol classically)
- Radiation
- Viral infections (hepatitis-associated, EBV, HIV, parvovirus context-dependent)
- Autoimmune disorders
- Inherited marrow-failure syndromes
Clinical features
- From anemia: fatigue, pallor
- From neutropenia: recurrent/severe infections
- From thrombocytopenia: petechiae, mucosal bleeding, ecchymoses
- Usually no splenomegaly (helps differential)
Labs and diagnosis
- CBC: pancytopenia
- Reticulocyte count: low
- Smear: reduced cells, no specific hemolysis pattern
- Bone marrow aspirate/biopsy: hypocellularity with fatty replacement
- Exclude mimics: MDS, leukemia, marrow infiltration, severe megaloblastic anemia
Severity (conceptual)
Based on neutrophils, platelets, reticulocytes, and marrow cellularity (non-severe, severe, very severe).
Treatment
- Supportive: RBC/platelet transfusions, infection prevention/treatment
- Remove causative exposure where possible
- Disease-modifying:
- Immunosuppressive therapy (ATG + cyclosporine ± thrombopoietin receptor agonist)
- Allogeneic stem-cell transplantation (preferred in many younger severe cases with donor)
- Long-term monitoring for clonal evolution (MDS/AML risk in some patients)
Prognosis
Varies by severity, age, treatment access, infection/bleeding complications.
4) Hemolytic anemia
Definition
Anemia due to shortened RBC survival from premature destruction.
Classification
- By site
- Intravascular hemolysis
- Extravascular hemolysis (usually spleen/liver)
- By origin
- Inherited: membrane (spherocytosis), enzyme (G6PD), hemoglobinopathies
- Acquired: autoimmune, microangiopathic, infections, drugs, mechanical valves, hypersplenism
Pathophysiology
RBC destruction exceeds marrow compensatory production (reticulocytosis). If compensation fails, anemia develops.
Clinical features
- Fatigue, pallor
- Jaundice, scleral icterus
- Dark urine (especially intravascular hemolysis)
- Splenomegaly (often extravascular forms)
- Pigment gallstones in chronic hemolysis
Core hemolysis labs
- Reticulocytes high
- LDH high
- Indirect bilirubin high
- Haptoglobin low
- Smear morphology provides clues:
- Spherocytes (AIHA/hereditary spherocytosis)
- Schistocytes (MAHA, prosthetic valves)
- Bite cells/Heinz body context (oxidative hemolysis)
Key confirmatory tests
- Direct antiglobulin (Coombs) test for immune hemolysis
- G6PD assay, hemoglobin electrophoresis, osmotic fragility/EMA test, ADAMTS13 etc. as indicated by context
Treatment principles
- Treat cause
- Autoimmune hemolysis: corticosteroids first line, then rituximab/other options if refractory
- Avoid triggers in enzymopathies
- Folate supplementation in chronic hemolysis
- Transfusions when needed
- Splenectomy in selected conditions
High-yield differential summary
| Feature | Iron deficiency | B12/Folate deficiency | Aplastic anemia | Hemolytic anemia |
|---|
| MCV | Low | High | Often normal (can vary) | Normal or high (reticulocytosis) |
| Reticulocytes | Low/normal | Low (pre-treatment) | Low | High |
| WBC/Platelets | Usually normal (late changes possible) | Usually normal/mild changes | Low (pancytopenia) | Usually normal unless specific disorder |
| Signature labs | Ferritin low, TSAT low, TIBC high | B12 or folate low; MMA high only in B12 | Hypocellular marrow | LDH high, indirect bilirubin high, haptoglobin low |
| Smear | Microcytic hypochromic cells | Macro-ovalocytes, hypersegmented neutrophils | No specific morphology | Spherocytes/schistocytes etc. |
| Marrow | Iron-depleted stores | Megaloblastic erythropoiesis | Fatty hypocellular marrow | Erythroid hyperplasia (if compensating) |
Practical stepwise approach in a patient with anemia
- CBC + indices + reticulocyte count + smear
- If microcytic -> iron studies
- If macrocytic -> B12, folate, MMA, homocysteine
- If retic high -> hemolysis panel (LDH, bilirubin, haptoglobin, Coombs)
- If pancytopenia + retic low -> marrow evaluation for aplasia/hypoplasia
If you want, I can provide this same content as:
- a single exam revision sheet (1 page), or
- a management protocol format (what to do on day 1, week 1, month 1).